Showing results (1321-1330 of 3,105) with videos related to

Sort By:
Pageof 311
Drug Safety|March 13, 2024
The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE)Meredith Y Smith, Elaine H Morrato, Nallely Mora, et al.
Drug Safety|March 5, 2024
Risk Factors Associated with Medication Administration Errors in Children: A Prospective Direct Observational Study of Paediatric InpatientsJohanna I Westbrook, Ling Li, Amanda Woods, et al.
Drug Safety|January 25, 2024
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic ReviewBronya Calvarysky, Idit Dotan, Daniel Shepshelovich, et al.
Drug Safety|December 7, 2023
Optimizing Signal Management in a Vaccine Adverse Event Reporting System: A Proof-of-Concept with COVID-19 Vaccines Using Signs, Symptoms, and Natural Language ProcessingGuojun Dong, Andrew Bate, François Haguinet, et al.
Drug Safety|November 15, 2023
Enhancing Pharmacovigilance in Côte d'Ivoire: Impact of GSK's Training and Mentoring Pilot Project in the Abidjan RegionYolanda Guerra Mendoza, Viviane Jusot, Félix Adou, et al.
Drug Safety|November 7, 2023
Application of an Innovative Data Mining Approach Towards Safe Polypharmacy Practice in Older AdultsYi Shi, Chien-Wei Chiang, Kathleen T Unroe, et al.
Drug Safety|July 11, 2024
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare ProfessionalsCarlotta Lunghi, Marco Domenicali, Stefano Vertullo, et al.
Drug Safety|June 1, 2024
Key Opinion Leaders' Interviews to Inform the Future of Benefit-Risk Planning in the Medical Total Product Life Cycle of Global Pharmaceutical and Medical Device OrganizationsArianna Simonetti, Susan Colilla, Brian Edwards, et al.
Drug Safety|July 9, 2024
Optimal Significance Levels and Sample Sizes for Signal Detection Methods Based on Non-constant HazardsOdile Sauzet, Julia Dyck, Victoria Cornelius
Drug Safety|July 9, 2024
A Calculated Risk: Evaluation of QTc Drug-Drug Interaction (DDI) Clinical Decision Support (CDS) Alerts and Performance of the Tisdale Risk Score CalculatorRachel L Wasserman, Diane L Seger, Mary G Amato, et al.
Pageof 311